Log in to search using one of your social media accounts:

 

Antipsychotic Polypharmacy With Risperidone and Olanzapine Antipsychotic Polypharmacy With Risperidone and Olanzapine

Given high rates of treatment failure for initial therapy of schizophrenia, is combining risperidone and olanzapine an appropriate approach to improve clinical response and limit adverse effects?Medscape Pharmacists
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Pharmacist Ask the Expert Source Type: news

Related Links:

Molecular Psychiatry, Published online: 17 October 2017; doi:10.1038/mp.2017.170
Source: Molecular Psychiatry - Category: Psychiatry Authors: Source Type: research
If it disagrees with experiment it is wrong. In that simple statement is the key to science. It does not make any difference how beautiful your guess is. It does not make any difference how smart you are, who made the guess, or what his name is – if it disagrees with experiment it is wrong. That is all there is to it.—Richard Feynman (1)
Source: Biological Psychiatry - Category: Psychiatry Authors: Tags: Commentary Source Type: research
In this issue of Biological Psychiatry, Hartz et  al. (1) report evidence for common genetic origins of schizophrenia and addiction using a relatively new method, the polygenic risk score (PRS). Genome-wide association (GWA) has implicated many single nucleotide polymorphisms (SNPs) and genes in psychiatric disease, but identified few functional loci, with notable exceptions, such as the CHRNA5 Asn398Asp locus in smoking, nearly simultaneously implicated by pathway analysis (2). Discovery of circuits, cells, and molecules integral to psychiatric diseases has been accomplished largely without the aid of GWA.
Source: Biological Psychiatry - Category: Psychiatry Authors: Tags: Commentary Source Type: research
Previous research on moral judgement in healthy adults suggests a complex interplay of automatic, emotional and deliberative processing. We aimed to advance understanding of these processes by examining moral judgement in individuals with schizophrenia, a ...
Source: SafetyLit - Category: International Medicine & Public Health Tags: Risk Factor Prevalence, Injury Occurrence Source Type: news
This article aims to examine the effect of writing when used as self-medication in psychosis and particularly in schizophrenia. It is based on the work of Antonin Artaud, who engaged in writing to reduce his physical and psychological dissociation and intr...
Source: SafetyLit - Category: International Medicine & Public Health Tags: Risk Factor Prevalence, Injury Occurrence Source Type: news
Compared with those admitted for other medical conditions, patients admitted for epilepsy show increases in subsequent schizophrenia readmissions, a new study suggests.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news
Source: Psychopharmacology - Category: Psychiatry Source Type: research
Hospital discharge planning for clients with schizophrenia reduces client rehospitalization rates and improves their medication adherence. The effectiveness of caregiver participation in hospital discharge planning has seldom been explored. The purpose of this study was to examine the effectiveness of caregiver participation in hospital discharge planning for clients with schizophrenia in reducing caregiver burden and improving health status. A quasi-experimental research design was adopted. The research location was in a psychiatric hospital in Northern Taiwan.
Source: Archives of Psychiatric Nursing - Category: Nursing Authors: Source Type: research
Psychiatric Services, Ahead of Print.
Source: Psychiatric Services - Category: Psychiatry Authors: Source Type: research
The excitatory, ligand-gated α7 nicotinic acetylcholine receptor (nAChR) has been implicated in the pathophysiology of schizophrenia based on convergent genetic, post-mortem, and psychopharmacological studies (reviewed in Freedman, 2014). Preclinical animal studies (reviewed in Lewis et al., 2017), as well as early phase clini cal studies of patients with schizophrenia (Olincy et al., 2006), suggest α7 nAChR agonists may be useful for treatment of cognitive dysfunction in schizophrenia. However, results of larger randomized placebo-controlled clinical trials of α7 nAChR agonists with a primary cognitive o...
Source: Schizophrenia Research - Category: Psychiatry Authors: Tags: Letter to the Editor Source Type: research
More News: Health | Risperdal Consta | Schizophrenia | Zyprexa